- Home
- RNA vs NVST Comparison
RNA vs NVST Comparison
Compare RNA & NVST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RNA
- NVST
- Stock Information
- Founded
- RNA 2012
- NVST 2018
- Country
- RNA United States
- NVST United States
- Employees
- RNA N/A
- NVST N/A
- Industry
- RNA Biotechnology: Pharmaceutical Preparations
- NVST Medical/Dental Instruments
- Sector
- RNA Health Care
- NVST Health Care
- Exchange
- RNA Nasdaq
- NVST Nasdaq
- Market Cap
- RNA 3.7B
- NVST 3.3B
- IPO Year
- RNA 2020
- NVST 2019
- Fundamental
- Price
- RNA $31.12
- NVST $20.87
- Analyst Decision
- RNA Strong Buy
- NVST Hold
- Analyst Count
- RNA 10
- NVST 12
- Target Price
- RNA $65.80
- NVST $20.32
- AVG Volume (30 Days)
- RNA 1.3M
- NVST 2.3M
- Earning Date
- RNA 03-07-2025
- NVST 02-05-2025
- Dividend Yield
- RNA N/A
- NVST N/A
- EPS Growth
- RNA N/A
- NVST N/A
- EPS
- RNA N/A
- NVST N/A
- Revenue
- RNA $10,117,000.00
- NVST $2,510,600,000.00
- Revenue This Year
- RNA N/A
- NVST $4.24
- Revenue Next Year
- RNA N/A
- NVST $3.40
- P/E Ratio
- RNA N/A
- NVST N/A
- Revenue Growth
- RNA N/A
- NVST N/A
- 52 Week Low
- RNA $13.73
- NVST $15.15
- 52 Week High
- RNA $56.00
- NVST $23.06
- Technical
- Relative Strength Index (RSI)
- RNA 44.06
- NVST 49.55
- Support Level
- RNA $31.14
- NVST $20.42
- Resistance Level
- RNA $33.37
- NVST $22.24
- Average True Range (ATR)
- RNA 1.67
- NVST 0.76
- MACD
- RNA -0.16
- NVST -0.03
- Stochastic Oscillator
- RNA 11.27
- NVST 49.44
About RNA Avidity Biosciences Inc.
Avidity Biosciences Inc is a biotechnology company. The company develops novel Antibody Oligonucleotide Conjugates therapies designed to overcome the current limitations of oligonucleotide therapies in order to treat a wide range of serious diseases. Its product, AOC 1001, is designed to treat a rare monogenic muscle disease.
About NVST Envista Holdings Corporation
Envista Holdings Corp is a dental products company. It develops, manufactures, and markets portfolios of dental consumables, equipment, and services to dental professionals. The company's business consists of two segments comprising Specialty Products and Technologies and Equipment and Consumables. The Company's Specialty Products & Technologies segment develops, manufactures, and markets dental implant systems, including regenerative solutions, dental prosthetics, and associated treatment software and technologies, as well as orthodontic bracket systems, aligners, and lab products. The Company's Equipment & Consumables segment manufactures dental equipment and supplies used in dental offices, including digital imaging systems, software and other visualization/magnification systems.